MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic Keratosis

NCT05152407 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis
Actinic Lentigo

Interventions

OTHER: Topical application of MRB 0.3% serum and placebo serum (hemi face or skull)

Sponsor

NAOS Institute of Life Science